Michael Newton, Pharm.D., BCOP

Clinical Assistant Professor

Department of Clinical Pharmacy
West Virginia University School of Pharmacy
1124 Health Sciences North
P.O. Box 9520
Morgantown, WV 26506-9520

Phone: (304)293.8170
Fax: (304)293.7672
E-Mail: mnewton@hsc.wvu.edu
Link to Full CV - PDF

BIOSKETCH

Michael Newton, PharmD, BCOP is a Clinical Assistant Professor at the West Virginia University School of Pharmacy and Clinical Specialist in Hematology/Oncology at West Virginia University Hospitals in Morgantown, West Virginia. Dr. Newton earned his BS in pharmacy and Doctor of Pharmacy degree at WVU. He subsequently completed a specialty residency in Internal Medicine at WVU Hospitals. Dr. Newton spent the next 7 ½ years as a clinical pharmacist at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, an NCI designated Comprehensive Cancer Center and member of the National Comprehensive Cancer Network (NCCN). During his time at Moffitt, Newton served on multiple committees and served as primary preceptor for the Oncology Specialty Residency’s ambulatory oncology rotation. He returned to West Virginia in January 2008 to serve in his current position. His practice interests include neuro-oncology, malignant hematology, pharmacogenomics, and targeted therapy.

Educational Background

Specialty Residency in Adult Internal Medicine
West Virginia University Hospitals Morgantown, West Virginia
July 2000

Doctor of Pharmacy
West Virginia University School of Pharmacy Morgantown, West Virginia
May 1999

Bachelor of Science in Pharmacy
West Virginia University School of Pharmacy Morgantown, West Virginia
May 1997

Teaching Interests

Acute and ambulatory care pharmacy, oncology, malignant hematology, clinical applications of pharmacogenomics.

Courses Taught

PHAR 730: Pathophysiology and Therapeutics 3: Clinical Review of Antineoplastics, Oncologic Emergencies, Lymphomas, Colorectal Cancer, Lung Cancer
PHAR 735: Clinical Oncology and Chemotherapy Lab
PHAR 739: Clinical Monitoring of the Cancer Patient
PHAR 741: Methotrexate Pharmacokinetics
PHAR 742: IPPE 5 small group facilitator
PHAR 762: APPE Ambulatory Care Rotation in Oncology
PHAR 791Y: Oncology Acute Care Cases

Practice/Research Interests

Neuro-oncology
Malignant hematology
Pharmacogenomics
Targeted therapy

Selected Presentations

Clinically Relevant Interactions Involving Anti-Cancer Drugs.
ACPE/CME accredited educational presentation at 2009 West Virginia Society of Oncology’s Fall Cancer Conference Morgantown, WV Oct 9, 2009.

Cancer Update: New Antineoplastic Agents
ACPE accredited presentation at the West Virginia Society of Health System Pharmacists Meeting April 2008.

Selected Publications

Almubarak M, Newton MD. Novel and targeted agents for gastrointestinal tumors. In: Emerging Cancer Therapeutics: Gastrointestinal Malignancies. Saif, MW and Abraham J ed. New York, NY: Demos Medical Publishing, 2010; 179-188.

Newton M. From the administrator’s desk: Romiplostim: The risk evaluation and mitigation strategy. Commun Oncol 2008; 5:654-5.

Newton MD, Wetzstein G, Sullivan D,. “Topoisomerase II Inhibitors”. In: Cancer Growth and Progression, 2nd Edition [editor: Minev, B] (in press).

Other WVU Academic Teaching Instruction

CCB 702: Cancer Pharmacology and Therapeutics: Signal Transduction Inhibitors

Editorial Responsibilities

Manuscript Reviewer - Annals of Pharmacotherapy

Professional Memberships

Hematology Oncology Pharmacy Association (HOPA) Charter Member
American College of Clinical Pharmacy (ACCP)
American Society of Health-System Pharmacists (ASHP)
West Virginia Pharmacists Association (WVPA)